1. Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections

   • Eric Wenzler
   • Debra A. Goff
   • Ellie J. C. Goldstein

   Review Open access 04 March 2017 Pages: 149 - 172

2. The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood

   • Brigitte Fauroux
   • Eric A. F. Simões
   • Xavier Carbonell-Estrany

   Review Open access 29 March 2017 Pages: 173 - 197

   

3. Minocycline for the Treatment of Multidrug and Extensively Drug-Resistant A. baumannii: A Review

   • Jennifer N. Lashinsky
   • Oryan Henig
   • Keith S. Kaye

   Review Open access 29 March 2017 Pages: 199 - 211

4. A Review of Diagnostic Methods for Invasive Fungal Diseases: Challenges and Perspectives

   • Diego R. Falci
   • Claudio M. B. Stadnik
   • Alessandro C. Pasqualotto

   Review Open access 29 March 2017 Pages: 213 - 223

   

5. The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections

   • Lauren K. Flynt
   • Rachel M. Kenney
   • Susan L. Davis

   Original Research Open access 06 March 2017 Pages: 225 - 231

   

6. Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012

   • Tiffany R. Keepers
   • Marcela Gomez
   • Ian Critchley

   Original Research Open access 11 March 2017 Pages: 233 - 243

7. Risk Factors For and Outcomes of Multidrug-Resistant Escherichia coli Infections in Children

   • Adaora S. Uzodi
   • Christine M. Lohse
   • Ritu Banerjee

   Original Research Open access 03 April 2017 Pages: 245 - 257

8. Use of High-Dose Oral Valacyclovir During an Intravenous Acyclovir Shortage: A Retrospective Analysis of Tolerability and Drug Shortage Management

   • Milena M. McLaughlin
   • Sarah H. Sutton
   • John S. Esterly

   Brief Report Open access 17 April 2017 Pages: 259 - 264

9. Chronic Hepatitis C Treatment in Patients with Drug Injection History: Findings of the INTEGRATE Prospective, Observational Study

   • Geert Robaeys
   • Stefan Christensen
   • Graham R. Foster

   Brief Report Open access 05 May 2017 Pages: 265 - 275

   

10. Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections

    • Cassie L. Stewart
    • Michelle S. Turner
    • Jordan R. Smith

    Case Series Open access 06 April 2017 Pages: 277 - 289

11. Persistent Hepatitis E Infection in a Patient with Tuberous Sclerosis Complex Treated with Everolimus: A Case Report

    • Wobke E. M. van Dijk
    • Menno A. M. H. Vergeer
    • Joop E. Arends

    Case Report Open access 03 March 2017 Pages: 291 - 295

    

12. Comment on Nuño Solinís R, et al. “Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence”

    • Patrice Cacoub

    Letter Open access 29 March 2017 Pages: 297 - 301